Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-10 2:03 pm Purchase | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD GROUP INC | 12,404,050 10.01% | 1,731,974 (+16.23%) | View |
| 2024-02-13 4:58 pm Sale | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD GROUP INC | 10,672,076 9.93% | -158,357 (-1.46%) | View |
| 2024-01-24 12:57 pm Purchase | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | STATE STREET CORP STT | 6,825,111 6.35% | 854,767 (+14.32%) | View |
| 2024-01-23 4:14 pm Purchase | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | BlackRock Inc. BLK | 13,303,281 12.4% | 592,650 (+4.66%) | View |
| 2023-06-09 2:15 pm Purchase | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD GROUP INC | 10,830,433 10.13% | 544,261 (+5.29%) | View |
| 2023-02-09 11:07 am Purchase | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD GROUP INC | 10,286,172 9.7% | 646,029 (+6.70%) | View |
| 2023-02-08 10:08 am Purchase | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | STATE STREET CORP STT | 5,970,344 5.63% | 1,845,874 (+44.75%) | View |
| 2023-01-26 08:52 am Unchanged | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | BlackRock Inc. BLK | 12,710,631 12% | 0 (Unchanged) | View |
| 2023-01-20 09:43 am Purchase | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | BlackRock Inc. BLK | 12,710,631 12% | 702,568 (+5.85%) | View |
| 2022-02-09 3:24 pm Purchase | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD GROUP INC | 9,640,143 9.22% | 358,592 (+3.86%) | View |
| 2022-01-27 11:00 am Unchanged | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | BlackRock Inc. BLK | 12,008,063 11.5% | 0 (Unchanged) | View |
| 2022-01-25 3:03 pm Sale | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | BlackRock Inc. BLK | 12,008,063 11.5% | -555,069 (-4.42%) | View |
| 2021-02-10 10:30 am Sale | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD GROUP INC | 9,281,551 9.03% | -515,956 (-5.27%) | View |
| 2021-01-26 6:52 pm Purchase | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | BlackRock Inc. BLK | 12,563,132 12.2% | 202,174 (+1.64%) | View |
| 2020-02-14 1:43 pm Sale | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | RTW INVESTMENTS LP | 0 0% | -5,316,156 (Position Closed) | View |
| 2020-02-13 1:58 pm Sale | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | STATE STREET CORP STT | 4,124,470 4.12% | -949,305 (-18.71%) | View |
| 2020-02-11 7:35 pm Sale | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD GROUP INC | 9,797,507 9.78% | -1,047,064 (-9.66%) | View |
| 2020-02-04 2:47 pm Sale | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | FIRST MANHATTAN CO. LLC. | 2,821,725 2.96% | -3,020,805 (-51.70%) | View |
| 2020-02-04 11:53 am Sale | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | BlackRock Inc. BLK | 12,360,958 12.3% | -2,508,322 (-16.87%) | View |
| 2019-10-10 10:56 am Purchase | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD GROUP INC | 10,844,571 11.37% | 10,844,571 (New Position) | View |